Inflammation and Sepsis: Past, Present, and the Future
暂无分享,去创建一个
[1] Juan E. González,et al. Messing with Bacterial Quorum Sensing , 2006, Microbiology and Molecular Biology Reviews.
[2] A. V. Bubnoff. Seeking New Antibiotics in Nature's Backyard , 2006, Cell.
[3] G. Stormo,et al. Molecular Diagnostics in Sepsis: From Bedside to Bench , 2006, Journal of the American College of Surgeons.
[4] Nicki Panoskaltsis,et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. , 2006, The New England journal of medicine.
[5] R. Gamelli,et al. OxyR gene expression of Pseudomonas aeruginosa regulates bone marrow dendritic cell differentiation and function after burn sepsis , 2006 .
[6] Roberto Rebeil,et al. Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Gamelli,et al. Immunologic Responses to Critical Injury and Sepsis , 2006, Journal of intensive care medicine.
[8] R. Gamelli,et al. New Perspectives for a New Century: Implications of Pathogen Responses for the Future of Antimicrobial Therapy , 2006, Journal of burn care & research : official publication of the American Burn Association.
[9] Paul Martin,et al. Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.
[10] John D. Storey,et al. A network-based analysis of systemic inflammation in humans , 2005, Nature.
[11] I. Jutras,et al. Phagocytosis: at the crossroads of innate and adaptive immunity. , 2005, Annual review of cell and developmental biology.
[12] Kazuo Kobayashi,et al. Macrophages in inflammation. , 2005, Current drug targets. Inflammation and allergy.
[13] G. S. Chhatwal,et al. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. , 2005, The Journal of infectious diseases.
[14] Mehmet Toner,et al. Application of genome-wide expression analysis to human health and disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Dixon,et al. Functions of the Yersinia effector proteins in inhibiting host immune responses. , 2005, Current opinion in microbiology.
[16] Dean Cheng,et al. Pseudomonas aeruginosa Genome Database and PseudoCAP: facilitating community-based, continually updated, genome annotation , 2004, Nucleic Acids Res..
[17] D. Herndon,et al. Influence of systemic inflammatory response syndrome on host resistance against bacterial infections* , 2004, Critical care medicine.
[18] Roger S Smith,et al. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. , 2003, The Journal of clinical investigation.
[19] D. Mannino,et al. The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.
[20] M. Schwacha. Macrophages and post-burn immune dysfunction. , 2003, Burns : journal of the International Society for Burn Injuries.
[21] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[22] J. W. Wilson,et al. Mechanisms of bacterial pathogenicity , 2002, Postgraduate medical journal.
[23] D. Chinkes,et al. Reversal of catabolism by beta-blockade after severe burns. , 2001, The New England journal of medicine.
[24] L. Moldawer,et al. SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.
[25] D. Hassett,et al. Role of the Pseudomonas aeruginosa oxyR-recG Operon in Oxidative Stress Defense and DNA Repair: OxyR-Dependent Regulation of katB-ankB, ahpB, andahpC-ahpF , 2000, Journal of bacteriology.
[26] P. Delves,et al. The Immune System , 2000 .
[27] E. Abraham,et al. Why immunomodulatory therapies have not worked in sepsis , 1999, Intensive Care Medicine.
[28] S. Nasraway,et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.
[29] Wiklund Ra,et al. First of two parts , 1997 .
[30] B. G. Sparkes. Immunological responses to thermal injury. , 1997, Burns : journal of the International Society for Burn Injuries.
[31] R. Bone. A personal experience with SIRS and MODS. , 1996, Critical care medicine.
[32] R. Bone,et al. Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.
[33] R. Bone. The sepsis syndrome. Definition and general approach to management. , 1996, Clinics in chest medicine.
[34] T. Kupper,et al. Immunity at the surface: homeostatic mechanisms of the skin immune system. , 1996, Life sciences.
[35] L. DiPietro,et al. WOUND HEALING: THE ROLE OF THE MACROPHAGE AND OTHER IMMUNE CELLS , 1995, Shock.
[36] Bonnie L. Bassler,et al. Bacterially Speaking , 2006, Cell.
[37] R. Steinman,et al. Dendritic cells: translating innate to adaptive immunity. , 2006, Current topics in microbiology and immunology.
[38] J. Dunne,et al. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. , 2004, Surgical infections.
[39] M. Eaman. Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[40] S. Nasraway,et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. , 1998, Lancet.
[41] P. Nyström,et al. The systemic inflammatory response syndrome: definitions and aetiology. , 1998, The Journal of antimicrobial chemotherapy.
[42] E. Faist. The mechanisms of host defense dysfunction following shock and trauma. , 1996, Current topics in microbiology and immunology.